Related Experiment Video

Updated: May 5, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

16.6K

Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease

M Ligumsky1, P L Simon, F Karmeli

  • 1Department of Gastroenterology, Hadassah University Hospital, Hebrew University Hadassah Medical School, Jerusalem, Israel.

Gut
|June 1, 1990
PubMed

Insights

Interleukin 1 (IL-1) levels are significantly elevated in the colonic mucosa of patients with active inflammatory bowel disease (IBD). This finding suggests IL-1 plays a key role in IBD pathogenesis and that suppressing its production may offer therapeutic benefits.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cytokine research

Background:

  • Interleukin 1 (IL-1) is a key cytokine in immune and inflammatory responses.
  • IL-1 acts as a dominant mediator and marker of inflammation in experimental colitis.

Purpose of the Study:

  • To quantify in vitro the production and release of IL-1 from colonic mucosa in patients with active, untreated inflammatory bowel disease (IBD).
  • To compare IL-1 levels in patients with ulcerative colitis and Crohn's disease of the colon against normal controls.

Main Methods:

  • Colonic mucosal biopsies were obtained from 17 ulcerative colitis patients, 8 Crohn's disease patients, and 16 controls.
  • IL-1 content was measured in fresh mucosa, 24-hour organ cultured mucosa, and culture medium.
  • The effect of varying doses of prednisolone on IL-1 release was assessed.

Main Results:

  • IL-1 content and release were significantly higher in inflamed mucosa compared to controls.
  • A dose-dependent inhibition of IL-1 release was observed with prednisolone treatment.
  • These results indicate elevated IL-1 production in active IBD.

Conclusions:

  • Colonic mucosal IL-1 is significantly increased in active IBD, suggesting a role in disease pathogenesis.
  • Pharmacological suppression of IL-1 production could be a potential therapeutic strategy for IBD.
  • Further research into IL-1's role and targeted therapies is warranted.

More Related Videos

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice10:30

Visualization of IL-22-expressing Lymphocytes Using Reporter Mice

Published on: January 25, 2017

8.4K
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.5K

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
897
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
57
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64